References
- Godley , P.A. and Ataga , K.I. 2000 . “Renal cell carcinoma” . Curr. Opin. Oncol. , 12 (3) : 260 – 264 .
- Motzer , R.J. , Bander , N.H. and Nanus , D.M. 1996 . “Renal-cell carcinoma” . N. Engl. J. Med. , 335 (12) : 865 – 875 .
- Motzer , R.I. , Mazumdar , M. , Bacik , I. , Berg , W. , Amsterdam , A. and Ferrara , I. 1999 . “Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma” . J. Clin. Oncol. , 17 (8) : 25 – 30 .
- Bombardieri , E. , Pizzichetta , M. , Veronesi , P. , Seregni , E. , Bogni , A. Maffioli , L. 1992 . “CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases” . EUT. J. Cancer , 29A (1) : 144 – 146 .
- Hayes , D.F. , Zurawski , V.R. Jr. and Kufe , D.W. 1986 . “Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer” . J. Clin. Oncol. , 4 (10) : 1542 – 1550 .
- Nakamura , T. , Hayama , M. and Shimada , M. 1995 . “Expression of CA15-3 in renal cell carcinoma [letter]” . Pathol. Int. , 45 (10) : 787 – 789 .
- Masuda , H. , Kurita , Y. , Suzuki , A. , Kanbayashi , T. , Suzuki , K. and Fujita , K. 1997 . “Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases” . Int. J. Urol. , 4 (3) : 247 – 253 .
- Grankvist , K. , Ljungberg , B. and Rasmuson , T. 1997 . “Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma” . Int. J. Cancer , 74 (2) : 233 – 236 .
- Huber , P.R. , Bischof , P. , Kretschmer , R. , Truschnig , M. , Halwachs , G. and Schmidt , M. 1996 . “CA 15-3: a multicentre evaluation of automated and manual tests” . EUT. J. Clin. Chan. Clin. Biochem. , 34 (1) : 77 – 84 .
- McLaughlin , J.K. , Mandel , J.S. , Blot , W.I. , Schuman , L.M. , Mehl , E.S. and Fraumeni , J.F. Jr. 1984 . “A population-based casecontrol study of renal cell carcinoma” . J. Nail Cancer Inst. , 72 (2) : 275 – 284 .
- Levy , D.A. , Swanson , D.A. , Slaton , J.W. , Ellerhorst , I. and Dinney , C.P. 1998 . 'Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma” . J. Urol. , 159 (4) : 1168 – 1173 .
- Colomer , R. , Ruibal , A. , Navarro , M. , Encabo , G. , Sole , L.A. and Salvador , L. 1986 . “Circulating CA 15-3 levels in breast cancer. Our present experience” . Int. J. Biol. Markers , 1 (2) : 89 – 92 .
- Colomer , R. , Ruibal , A. and Salvador , L. 1989 . “Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease” . Cancer , 64 (8) : 1674 – 1681 .
- Levy , D.A. , Swanson , D.A. , Slaton , J.W. , Ellerhorst , J. and Dinney , C.P. 1998 . 'Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma” . J. Urol. , 159 (4) : 1168 – 1173 .
- Fujita , K. , Denda , K. , Yamamoto , M. , Matsumoto , T. , Fujime , M. and Irimura , T. 1999 . “Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients” . Br. J. Cancer , 80 (1-2) : 301 – 308 .
- Kraus , S. , Abel , P.D. , Nachtmann , C. , Linsenmann , H.J. , Weidner , W. Stamp , G.W. 2002 . “MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis” . Hum. Pathol. , 33 (1) : 60 – 67 .
- Pandey , P. , Kharbanda , S. and Kufe , D. 1995 . “Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein” . Cancer Res. , 55 (18) : 4000 – 4003 .